Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F4GN9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,349
Award facts
- Contract value 100% obligated
- $13,348.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract valued at $13,348.68, with completion expected by January 22, 2026. This is a non-set-aside, competitively awarded delivery order executed through AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains.
This delivery order represents a routine pharmaceutical procurement supporting the Defense Logistics Agency's mission to supply military treatment facilities and defense healthcare operations. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen's parent company, Cencora, Inc., maintains the overarching IDC with DLA Troop Support Medical that enables such task orders, positioning the company as a primary vendor for government pharmaceutical needs with demonstrated capability to compete successfully on a full and open basis across its extensive federal contract portfolio.
Quick answers
Who was awarded contract SPE2DR26F4GN9?
SPE2DR26F4GN9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F4GN9 worth?
The government has obligated $13,349 on SPE2DR26F4GN9.
Is contract SPE2DR26F4GN9 an order under another contract?
Yes. SPE2DR26F4GN9 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4GN9 competed?
The extent of competition for SPE2DR26F4GN9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award